bio-b: the income statement

MyFinsight

For the quarter ending 2025-09-30, BIO-B made $653,000K in revenue. -$341,900K in net income. Net profit margin of -52.36%.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Income Statement	2025-09-30
Net sales	653,000
Cost of goods sold	309,600
Gross profit	343,400
Selling, general and administrative expense	206,800
Research and development expense	71,300
Segment profit (loss)	65,300
Interest expense	12,300
Foreign exchange (gains) losses, net	2,900
Marketable securities, unrealized (gain) loss	-495,300
Other nonoperating income (expense)	8,300
Income (loss) from continuing operations before income taxes, noncontrolling interest	-431,100
(provision) benefit for income taxes	-89,200
Net income attributable to bio-rad	-341,900

Net income per share basic attributable to bio-rad	-12.7
Net income per share diluted attributable to bio-rad	-12.7
Weighted average common shares - basic	26,923,000
Weighted average common shares - diluted	26,923,000